Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

TENIPOSIDE for Bone marrow conditioning regimen: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

There are 9 adverse event reports in the FDA FAERS database where TENIPOSIDE was used for Bone marrow conditioning regimen.

Most Reported Side Effects for TENIPOSIDE

Side Effect Reports % Deaths Hosp.
Ototoxicity 71 22.4% 0 0
Off label use 61 19.2% 10 4
Product use in unapproved indication 53 16.7% 5 2
Leukopenia 25 7.9% 3 2
Bronchopulmonary aspergillosis 21 6.6% 20 0
Anaemia 20 6.3% 2 1
Histiocytosis haematophagic 18 5.7% 12 11
Left ventricular dysfunction 16 5.1% 0 1
Pancytopenia 16 5.1% 8 10
Alopecia 13 4.1% 0 1
Pneumocystis jirovecii pneumonia 13 4.1% 0 5
Cardiotoxicity 12 3.8% 2 2
Deafness 12 3.8% 0 0
Neutropenia 12 3.8% 6 1
Multiple organ dysfunction syndrome 11 3.5% 11 7

Other Indications for TENIPOSIDE

Retinoblastoma (69) Acute lymphocytic leukaemia (58) Burkitt's lymphoma (39) Neuroblastoma (35) Central nervous system lymphoma (19) Diffuse large b-cell lymphoma (15) Malignant lymphoid neoplasm (10) Non-hodgkin's lymphoma (9) Rhabdomyosarcoma (6) Burkitt's leukaemia (5)

Other Drugs Used for Bone marrow conditioning regimen

FLUDARABINE (6,080) BUSULFAN (4,669) CYCLOPHOSPHAMIDE (4,485) MELPHALAN (2,368) LAPINE T-LYMPHOCYTE IMMUNE GLOBULIN (1,884) THIOTEPA (1,551) ALEMTUZUMAB (1,122) ETOPOSIDE (936) CYTARABINE (833) THYMOCYTE IMMUNE GLOBULIN NOS (742)

Related Pages

TENIPOSIDE Full Profile All Bone marrow conditioning regimen Drugs TENIPOSIDE Demographics TENIPOSIDE Timeline